Related references
Note: Only part of the references are listed.Changes in Biomarkers of Exposure on Switching From a Conventional Cigarette to the glo Tobacco Heating Product: A Randomized, Controlled Ambulatory Study
Nathan Gale et al.
NICOTINE & TOBACCO RESEARCH (2021)
Reduction in Exposure to Selected Harmful and Potentially Harmful Constituents Approaching Those Observed Upon Smoking Abstinence in Smokers Switching to the Menthol Tobacco Heating System 2.2 for 3 Months (Part 1)
Christelle Haziza et al.
NICOTINE & TOBACCO RESEARCH (2020)
High density lipoprotein functionality and cardiovascular events and mortality: A systematic review and meta -analysis
Maria T. Soria-Florido et al.
ATHEROSCLEROSIS (2020)
Extended Exhaled Nitric Oxide Analysis in Interstitial Lung Diseases: A Systematic Review
Paolo Cameli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Favorable Changes in Biomarkers of Potential Harm to Reduce the Adverse Health Effects of Smoking in Smokers Switching to the Menthol Tobacco Heating System 2.2 for 3 Months (Part 2)
Christelle Haziza et al.
NICOTINE & TOBACCO RESEARCH (2020)
Statistical analysis plan for A randomised, controlled study to evaluate the effects of switching from cigarette smoking to using a tobacco heating product on health effect indicators in healthy subjects
Oscar M. Camacho et al.
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2020)
Biomarkers of Potential Harm: Summary of an FDA-Sponsored Public Workshop
Cindy M. Chang et al.
NICOTINE & TOBACCO RESEARCH (2019)
Changes in Biomarkers of Exposure on Switching From a Conventional Cigarette to Tobacco Heating Products: A Randomized, Controlled Study in Healthy Japanese Subjects
Nathan Gale et al.
NICOTINE & TOBACCO RESEARCH (2019)
Evaluating the effects of switching from cigarette smoking to using a heated tobacco product on health effect indicators in healthy subjects: study protocol for a randomized controlled trial
Nik Newland et al.
INTERNAL AND EMERGENCY MEDICINE (2019)
Effects of Switching to a Heat-Not-Burn Tobacco Product on Biologically Relevant Biomarkers to Assess a Candidate Modified Risk Tobacco Product: A Randomized Trial
Frank Luedicke et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2019)
Increases in Cigarette Consumption and Decreases in Smoking Intensity When Nondaily Smokers Are Provided With Free Cigarettes
Saul Shiffman et al.
NICOTINE & TOBACCO RESEARCH (2018)
Effects of Switching to the Menthol Tobacco Heating System 2.2, Smoking Abstinence, or Continued Cigarette Smoking on Clinically Relevant Risk Markers: A Randomized, Controlled, Open-Label, Multicenter Study in Sequential Confinement and Ambulatory Settings (Part 2)
Frank Ludicke et al.
NICOTINE & TOBACCO RESEARCH (2018)
Suitability of biomarkers of biological effects (BOBEs) for assessing the likelihood of reducing the tobacco related disease risk by new and innovative tobacco products: A literature review
Gerhard Scherer
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2018)
Assessment of tobacco heating product THP1.0. Part 2: Product design, operation and thermophysical characterisation
Dan Eaton et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2018)
Assessment of novel tobacco heating product THP1.0. Part 3: Comprehensive chemical characterisation of harmful and potentially harmful aerosol emissions
Mark Forster et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2018)
Quitting Smoking Among Adults — United States, 2000–2015
Stephen Babb et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2017)
Social smoking among intermittent smokers
Saul Shiffman et al.
DRUG AND ALCOHOL DEPENDENCE (2015)
Changes in levels of biomarkers of exposure and biological effect in a controlled study of smokers switched from conventional cigarettes to reduced-toxicant-prototype cigarettes
Christopher J. Shepperd et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2015)
Urinary Tobacco Smoke-Constituent Biomarkers for Assessing Risk of Lung Cancer
Jian-Min Yuan et al.
CANCER RESEARCH (2014)
Mechanisms of Cancer Induction by Tobacco-Specific NNK and NNN
Jiaping Xue et al.
CANCERS (2014)
Urinary biomarkers of smokers' exposure to tobacco smoke constituents in tobacco products assessment: a fit for purpose approach
Evan O. Gregg et al.
BIOMARKERS (2013)
Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL)
Monica Ter-Minassian et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Determinants of Tobacco Use and Renaming the FTND to the Fagerstrom Test for Cigarette Dependence
Karl Fagerstrom
NICOTINE & TOBACCO RESEARCH (2012)
Urinary biomarkers of oxidative/nitrosative stress in healthy smokers
Carlos Campos et al.
INHALATION TOXICOLOGY (2011)
Regulatory factors of basal F2-isoprostane formation: Population, age, gender and smoking habits in humans
Samar Basu et al.
FREE RADICAL RESEARCH (2009)
Biomarkers to assess the utility of potential reduced exposure tobacco products
Dorothy K. Hatsukami et al.
NICOTINE & TOBACCO RESEARCH (2006)
Leukocyte count and coronary heart disease - Implications for risk assessment
M Madjid et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Clearing the smoke: the science base for tobacco harm reduction - executive summary (Reprinted from National Academy Press, 2001)
K Stratton et al.
TOBACCO CONTROL (2001)
Share Paper
